Amphiphilic polymeric nanodrug integrated with superparamagnetic iron oxide nanoparticles for synergistic antibacterial and antitumor therapy of colorectal cancer
Source abstract
Abstract
Colorectal cancer (CRC) is one of the most prevalent and deadly malignancies that can be influenced by Fusobacterium nucleatum (Fn), a bacterium that promotes tumor development and chemoresistance, resulting in limited therapeutic efficacy. Traditional antibiotics cannot effectively eliminate Fn at tumor site due to issues like biofilm formation, while chemotherapy alone fails to suppress tumor progression. Therefore, the development of new methods to eliminate Fn and promote antitumor efficacy is of great significance for improving the outcome of CRC treatment. Herein, we developed a nanodrug (OPPL) that integrates oleic acid-modified superparamagnetic iron oxide nanoparticles (O-SPIONs) and an amphiphilic polymer (PPL) to deliver the platinum prodrug and antimicrobial lauric acid (LA) for enhancing the treatment of CRC. We demonstrated that OPPL can synergistically enhance antibacterial and biofilm disruption activities against Fn along with the antimicrobial LA by producing reactive oxygen species (ROS) through its peroxidase-like activity. Furthermore, the OPPL nanodrug can increase intracellular ROS, promote lipid peroxides and deplete glutathione, leading to ferroptosis. By combining chemotherapy and induced ferroptosis, the OPPL nanodrug exhibited high cytotoxicity against CRC cells. In vivo studies showed that the OPPL nanodrug could enhance tumor accumulation, enable magnetic resonance imaging, suppresse tumor growth, and inhibit growth of intratumor Fn. These results suggest that OPPL is an effective and promising candidate for the treatment of Fn-infected CRC. STATEMENT OF SIGNIFICANCE: The enrichment of Fusobacterium nucleatum (Fn) in colorectal cancer is reported to exacerbate tumor malignancy and is particularly responsible for chemoresistance. To this respect, we strategically elaborated multifaceted therapeutics, namely OPPL nanodrug, combining oleic acid-modified superparamagnetic iron oxide nanoparticles (O-SPIONs) with a polymer containing a platinum prodrug and antimicrobial lauric acid. The O-SPION components exert distinctive peroxidase-like activity, capable of stimulating Fenton reactions selectively in the tumor microenvironment, consequently accounting for the progressive production of reactive oxygen species. Hence, O-SPIONs have been demonstrated to not only supplement the antimicrobial activities of lauric acid in overcoming Fn-induced chemoresistance but also stimulate potent tumor ferroptosis. Our proposed dual antimicrobial and chemotherapeutic nanodrug provides an appreciable strategy for managing challenging Fn-infected colorectal cancer.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Inflammatory Biomarkers in Disease Prognosis · Immune cells in cancer
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (41)
Show source-provided references
1. Colorectal cancer statistics
2. Mechanisms of chemotherapeutic resistance and the application of targeted nanoparticles for enhanced chemotherapy in colorectal cancer10.1186/s12951-022-01586-4 ↗
3. Risk factors and risk prediction models for colorectal cancer metastasis and recurrence: an umbrella review of systematic reviews and meta-analyses of observational studies10.1186/s12916-020-01618-6 ↗
4. Fusobacterium nucleatum, a key pathogenic factor and microbial biomarker for colorectal cancer10.1016/j.tim.2022.08.010 ↗
5. Fusobacterium nucleatum-symbiont, opportunist and oncobacterium10.1038/s41579-018-0129-6 ↗
6. New roles for Fusobacterium nucleatum in cancer: target the bacteria, host, or both?10.1016/j.trecan.2020.11.006 ↗
7. Role of gut microbiota and bacterial metabolites in mucins of colorectal cancer10.1038/nrmicro3344 ↗
8. The role of Fusobacterium nucleatum in colorectal cancer: from carcinogenesis to clinical management
9. Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy10.1016/j.cell.2017.07.008 ↗
10. Drugs, bugs, and cancer: Fusobacterium nucleatum promotes chemoresistance in colorectal cancer10.1016/j.cell.2017.07.018 ↗
11. In situ-activated photothermal nanoplatform for on-demand NO gas delivery and enhanced colorectal cancer treatment10.1016/j.jconrel.2023.05.034 ↗
12. A dendritic polyamidoamine supramolecular system composed of pillar[5]arene and azobenzene for targeting drug-resistant colon cancer10.1039/D1TB02134F ↗
13. Gastrointestinal biofilms in health and disease10.1038/s41575-020-00397-y ↗
14. Microbiota organization is a distinct feature of proximal colorectal cancers10.1073/pnas.1406199111 ↗
15. Tolerance and resistance of microbial biofilms10.1038/s41579-022-00682-4 ↗
16. Bacterial biofilms in colorectal cancer initiation and progression10.1016/j.molmed.2016.11.004 ↗
17. Ferroptosis: an iron-dependent form of nonapoptotic cell death10.1016/j.cell.2012.03.042 ↗
18. Ferroptosis: death by lipid peroxidation10.1016/j.tcb.2015.10.014 ↗
19. Ferroptosis: mechanisms, biology and role in disease10.1038/s41580-020-00324-8 ↗
20. Recent progress of chemodynamic therapy-induced combination cancer therapy10.1016/j.nantod.2020.100946 ↗
21. Rigid shell decorated nanodevice with Fe/H2O2 supply and glutathione depletion capabilities for potentiated ferroptosis and synergized immunotherapy10.1002/adfm.202215022 ↗
22. Hybrid biomimetic membrane coated particles-mediated bacterial ferroptosis for acute MRSA pneumonia10.1021/acsnano.3c02365 ↗
23. For the greater good: programmed cell death in bacterial communities10.1016/j.micres.2017.11.016 ↗
24. Nano-decocted ferrous polysulfide coordinates ferroptosis-like death in bacteria for anti-infection therapy10.1016/j.nantod.2020.100981 ↗
25. Application of smart nanoparticles as a potential platform for effective colorectal cancer therapy10.1016/j.ccr.2021.213949 ↗
26. Mesoporous polydopamine carrying sorafenib and SPIO nanoparticles for MRI-guided ferroptosis cancer therapy10.1016/j.jconrel.2020.01.048 ↗
27. Superparamagnetic nanoparticles for biomedical applications10.1039/C9TB01955C ↗
28. A novel Fe3O4/CuOx nanozyme: intrinsic peroxidase-like activity to kill bacteria and sterilize wounds10.1016/j.apsusc.2023.157185 ↗
29. Peroxidase-like active nanomedicine with dual glutathione depletion property to restore oxaliplatin chemosensitivity and promote programmed cell death10.1021/acsnano.1c06777 ↗
30. Fenton reaction-independent ferroptosis therapy via glutathione and iron redox couple sequentially triggered lipid peroxide generator10.1016/j.biomaterials.2020.119911 ↗
31. Ferrocene-based polymeric nanoparticles carrying doxorubicin for oncotherapeutic combination of chemotherapy and ferroptosis10.1002/smll.202205024 ↗
32. Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy10.1016/j.addr.2010.05.006 ↗
33. Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers10.2147/IJN.S30320 ↗
34. Construction of size-transformable supramolecular nano-platform against drug-resistant colorectal cancer caused by Fusobacterium nucleatum10.1016/j.cej.2022.137605 ↗
35. Tumor-targeting nanoassembly for enhanced colorectal cancer therapy by eliminating intratumoral Fusobacterium nucleatum
36. Monodisperse MFe2O4 (M= Fe, Co, Mn) nanoparticles10.1021/ja0380852 ↗
37. Size-dependant cellular uptake of dendritic polyglycerol10.1002/smll.201002220 ↗
38. Recent advances in tumor targeting via EPR effect for cancer treatment10.3390/jpm11060571 ↗
39. Size-tunable strategies for a tumor targeted drug delivery system10.1021/acscentsci.9b01139 ↗
40. Oxidative stress cytotoxicity induced by platinum-doped magnesia nanoparticles in cancer cells10.1016/j.biopha.2021.111483 ↗
41. A GSH-depleted platinum (IV) prodrug triggers ferroptotic cell death in breast cancer10.1016/j.cclet.2022.03.105 ↗